[1] Zhang L, Long J, Jiang W, et al. Trends in chronic kidney disease in China [ J]. N Engl J Med,2016, 375(9):905-906.
[2] 段茜,刘东伟,刘风勋,等.血液透析和腹膜透析对终末期糖尿病肾病患者的疗效.医药论坛杂志,2018, 39(4):18-22.
[3] Li PK, Ohow &M, Van d Laijtpundew MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017 Feb;13(2):90-103.
[4] 黄振兴,马志宏.腹膜透析治疗终末期糖尿病肾病临床疗效及安全性评价.中国中西医结合肾病杂志,2018,19(06):63-64.
[5] 郑华，陈丽萌.腹膜糖暴露对腹透患者腹膜功能及预后的影响初探.北京协和医学院,2018.
[6] KUNJARA S, GREENBAUM AL, SOCHOR M, et al. Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes[J]. Int J Exp Pathol, 2014, 95(2): 95-100.
[7] Paniagua R，Amato D，Vonesh E，et al. Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J. Am. Soc. Nephrol. 2002, 13, 1307–1320.
[8] Williams JD, Craig KJ, Topley N, et al: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470–479.
[9] Mizumasa T, Hirakata H, Kuroki Y, et al. Diabetes influences peritoneal morphology in uremic patients at the initiation of deritoneal dialysis. Perit Dial Int 2013; 33: 175–181.
[10] Gillerot G, Goffin E, Michel C, et al. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67: 2477–2487.
[11] Chou MY, Kao MT, Lai MN, Chung SY. Comparisons of the peritoneal equilibration test and ultrafiltration in patients with and without diabetes mellitus on continuous ambulatory peritoneal dialysis. Am J Nephrol 2006; 26: 87–90.
[12] Ana Fernandes, Roi Ribera-Sanchez ,Ana Rodríguez-Carmona ,et al. Peritoneal Water Transport Characteristics of Diabetic Patients Undergoing Peritoneal Dialysis: A Longitudinal Study. A m J Nephrol 2017;46:47–54 .
[13] Serlie MJ, Struijk DG, de Blok K, Krediet RT. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD. Adv Perit Dial 1997; 13: 29–32.
[14] M.J. Fernández-Reyes1, M.A. Bajo Rubio, G. del Peso Gilsanz, et al. Kinetic studies with hypertonic glucose permit better identification of ultrafiltration failure. What is the contribution of sodium sieving. Nefrologia 2010;30(2):208-13.
[15] Nicanor Vega-Diaz, Fayna Gonzalez-Cabrera, Silvia Marrero-Robayna, et al：Renal Replacement Therapy: Purifying Efficiency of Automated Peritoneal Dialysis in Diabetic versus Non-Diabetic Patients. J Clin Med. 2015;4:1518-1535; doi:10.3390/jcm4071518.
[16] Andrew Davenport , Michelle Kay Willicombe：Does Diabetes Mellitus Predispose to Increased Fluid Overload in Peritoneal Dialysis Patients. Nephron Clin Pract 2010;114:c60–c66.
[17] 陈玉强, 汪年松.糖尿病肾病患者营养不良评估和治疗的研究进展[J].中国中西医结合肾病杂志, 2017,18(6):558-560.
[18] Kim JK, Song YR, Lee HS, et al. Repeated Bioimpedance Measurements Predict Prognosis of Peritoneal Dialysis Patients[J]. Am J Nephrol, 2018,47(2):120-129.
[19] 徐亚沛，郑娜．比较血液透析和腹膜透析对糖尿病肾病尿毒症的治疗效果［J］，糖尿病新世界，2016，19( 6):120-121．
[20] 盛琦琳，任棉，寿张飞.糖尿病腹膜透析患者的预后.中国血液净化,2019,18(9):600-602.
[21] 孙智恒.血液透析与腹膜透析治疗糖尿病肾病的临床效果评价［J］.中国现代药物应用,2020,14(03):58-59.
[22] Kyoko Kishida1,Yukio Maruyama1,Kana Asari1, et al. Clinical outcome of incident peritoneal dialysis patients with diabetic kidney disease. Clinical and Experimental Nephrology.2019.
[23] Schroijen MA, van de Luijtgaarden MW, Noordzij M, et al. Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia. 2013;56:1949-57.
[24] Fernandez Reyes MJ, Bajo MA, del Peso G, et al: The influence of initial peritoneal transport characteristics, inflammation, and high glucose exposure on prognosis for peritoneal membrane function. Perit Dial Int 2012; 32: 636–644.
[25] Mehrotra R, Ravel V, Streja E, Kuttykrishnan S, Adams SV, et al: Peritoneal equilibration test and patient outcomes. Clin J Am Soc Nephrol 2015; 10: 1990–2001.
[26] M A RT í N - L L A H í M , Pé PI N M , G U E VA R A M , et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study[J]. Gastroenteroloy, 2008, 134(5):1352 -1359.
[27] 蒋静,钟慧,秦敏,等.初始腹膜高转运特征与腹膜透析患者预后的关系.华西医学,2019, 34(7):752-758.
[28] Huang N, Chen J, Fan L, et al. High peritoneal transport status was not associated with mortality in peritoneal dialysis patients with diabetes. PLoS One, 2014, 9(10): e110445.
[29] Hong Wang, Junping Tian, Fenghe Du, et al. Effect of Peritoneal Transport Characteristics on Clinical Outcome in Nondiabetic and Diabetic Nephropathy Patients with Peritoneal Dialysis. Iran J Kidney Dis 2019;13:56-6.
[30] Guan JC, Bian W, Zhang XH, et al. Influence of Peritoneal Transport Characteristics on Nutritional Status and Clinical Outcome in Chinese Diabetic Nephropathy Patients on Peritoneal Dialysis. Chin Med J 2015;128:859-64.
